Applied Therapeutics, Inc.
NASDAQ: APLT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Les D. Funtleyder
- Employees
- 35
- Headquarters
- New York City, United States
- IPO year
- 2019
- Market cap
- $14.9M
- Website
- https://www.appliedtherapeutics.com
Loading APLT…
Loading profile data…Frequently asked questions about APLT
What does Applied Therapeutics, Inc. (APLT) do?
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is...
Where does APLT trade?
Applied Therapeutics, Inc. (APLT) trades on the NASDAQ Capital Market.
What sector is APLT in?
Applied Therapeutics, Inc. (APLT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Applied Therapeutics, Inc.?
Les D. Funtleyder is the chief executive officer of Applied Therapeutics, Inc. (APLT).
Where is Applied Therapeutics, Inc. headquartered?
Applied Therapeutics, Inc. is headquartered in United States.
Does APLT pay a dividend?
Applied Therapeutics, Inc. (APLT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APLT go public?
Applied Therapeutics, Inc. (APLT) completed its initial public offering in 2019.